Evidence map›Paper›PMID 39493900›Full record

ArticleBioImpacts : BI2024

Abuse potential of fentanyl and fentanyl analogues.

Anusha Thumma, Kwadwo Mfoafo, Niloofar Babanejad, Alborz Omidian, Yadollah Omidi, Hamid Omidian

Abstract read
In one paragraph

Article in BioImpacts : BI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anusha ThummaCollege of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States.ORCID https://orcid.org/0000-0003-2070-9941
Kwadwo MfoafoCollege of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States.
Niloofar BabanejadCollege of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States.
Alborz OmidianWestchester Medical Center, Department of Psychiatry, Valhalla, NY, United States.
Yadollah OmidiCollege of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States.
Hamid OmidianCollege of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States.ORCID https://orcid.org/0000-0002-5637-8729

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In this perspective review, we evaluated the clinical management of fatal fentanyl overdose in several routes of administration, concentrating on both legally prescribed and illegally produced formulations. Methods: A literature search was conducted on Web of Science, PubMed, and Google Scholar databases, using the following keywords: fentanyl, illicit fentanyl, deaths, misuse, abuse, and naloxone. We included only articles whose abstracts were available in English. All articles were screened using their abstracts to determine their relevance to the current review. Results: The gold standard for treating both acute and chronic pain is fentanyl, but abuse of the drug has exploded globally since the late 2000s. Fentanyl abuse has been shown to frequently result in serious harm and even death. Conclusion: By educating patients and physicians, making rescue kits easily accessible, developing vaccines to prevent opioid addiction, and perhaps even creating new tamper-resistant fentanyl formulations, it may be possible to prevent fentanyl misuse, therapeutic errors, and the repercussions that follow.

Indexed as

FentanylFentanyl abuseFentanyl analogousIllicit FentanylOpioid crisis

Identifiers

PMID39493900
PMCPMC11530972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.